> top > docs > PMC:7121452 > annotations

PMC:7121452 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 51-59 Species denotes Patients Tax:9606
4 18-29 Chemical denotes Aldosterone MESH:D000450
5 65-73 Disease denotes Covid-19 MESH:C000657245
21 479-510 Gene denotes angiotensin-converting enzyme 2 Gene:59272
22 512-516 Gene denotes ACE2 Gene:59272
23 679-683 Gene denotes ACE2 Gene:59272
24 820-824 Gene denotes ACE2 Gene:59272
25 850-854 Gene denotes ACE2 Gene:59272
26 1046-1049 Gene denotes ACE Gene:1636
27 202-207 Species denotes human Tax:9606
28 220-265 Species denotes Severe acute respiratory syndrome coronavirus Tax:694009
29 269-277 Species denotes SARS-CoV Tax:694009
30 285-295 Species denotes SARS-CoV-2 Tax:2697049
31 97-108 Chemical denotes aldosterone MESH:D000450
32 387-411 Disease denotes coronavirus disease 2019 MESH:C000657245
33 413-421 Disease denotes Covid-19 MESH:C000657245
34 930-938 Disease denotes Covid-19 MESH:C000657245
35 1157-1165 Disease denotes Covid-19 MESH:C000657245
47 1191-1194 Gene denotes ACE Gene:1636
48 1485-1489 Gene denotes ACE2 Gene:59272
49 1567-1571 Gene denotes ACE2 Gene:59272
50 1264-1272 Species denotes patients Tax:9606
51 1343-1349 Species denotes humans Tax:9606
52 1513-1519 Species denotes humans Tax:9606
53 1613-1621 Species denotes patients Tax:9606
54 1748-1756 Species denotes patients Tax:9606
55 1278-1286 Disease denotes Covid-19 MESH:C000657245
56 1627-1638 Disease denotes lung injury MESH:D055370
57 1781-1789 Disease denotes Covid-19 MESH:C000657245
59 1792-1800 Disease denotes Covid-19 MESH:C000657245
68 1944-1952 Species denotes patients Tax:9606
69 2234-2242 Species denotes patients Tax:9606
70 1925-1937 Disease denotes hypertension MESH:D006973
71 1958-1966 Disease denotes Covid-19 MESH:C000657245
72 2052-2060 Disease denotes Covid-19 MESH:C000657245
73 2170-2182 Disease denotes hypertension MESH:D006973
74 2358-2370 Disease denotes hypertension MESH:D006973
75 2387-2403 Disease denotes viral infections MESH:D001102
85 2554-2562 Species denotes patients Tax:9606
86 2700-2708 Species denotes patients Tax:9606
87 2484-2496 Disease denotes hypertension MESH:D006973
88 2568-2576 Disease denotes Covid-19 MESH:C000657245
89 2684-2688 Disease denotes died MESH:D003643
90 3031-3039 Disease denotes Covid-19 MESH:C000657245
91 3048-3053 Disease denotes death MESH:D003643
92 3280-3292 Disease denotes hypertension MESH:D006973
93 3376-3384 Disease denotes Covid-19 MESH:C000657245
101 3603-3611 Species denotes patients Tax:9606
102 3769-3777 Species denotes patients Tax:9606
103 3825-3833 Species denotes patients Tax:9606
104 4093-4101 Species denotes patients Tax:9606
105 3630-3642 Disease denotes hypertension MESH:D006973
106 3839-3847 Disease denotes Covid-19 MESH:C000657245
107 4107-4115 Disease denotes Covid-19 MESH:C000657245
109 4169-4173 Gene denotes ACE2 Gene:59272
125 4335-4339 Gene denotes ACE2 Gene:59272
126 4388-4402 Gene denotes angiotensin II Gene:183
127 4519-4533 Gene denotes angiotensin II Gene:183
128 4562-4566 Gene denotes ACE2 Gene:59272
129 4593-4606 Gene denotes angiotensin I Gene:183
130 4752-4756 Gene denotes ACE2 Gene:59272
131 4991-4995 Gene denotes ACE2 Gene:59272
132 5031-5035 Gene denotes ACE2 Gene:59272
133 4698-4704 Species denotes humans Tax:9606
134 4860-4870 Species denotes SARS-CoV-2 Tax:2697049
135 4478-4484 Chemical denotes sodium MESH:D012964
136 4610-4627 Chemical denotes angiotensin-(1–9)
137 4672-4680 Chemical denotes peptides MESH:D010455
138 4500-4508 Disease denotes fibrosis MESH:D005355
139 4888-4903 Disease denotes dominant injury MESH:D014947
152 5168-5171 Gene denotes ACE Gene:1636
153 5218-5232 Gene denotes angiotensin II Gene:183
154 5259-5263 Gene denotes ACE2 Gene:59272
155 5296-5300 Gene denotes ACE2 Gene:59272
156 5399-5402 Gene denotes ACE Gene:1636
157 5407-5411 Gene denotes ACE2 Gene:59272
158 5466-5469 Gene denotes ACE Gene:1636
159 5520-5524 Gene denotes ACE2 Gene:59272
160 5621-5624 Gene denotes ACE Gene:1636
161 5639-5643 Gene denotes ACE2 Gene:59272
162 5774-5778 Gene denotes ACE2 Gene:59272
163 5867-5871 Gene denotes ACE2 Gene:59272
205 6038-6042 Gene denotes ACE2 Gene:59272
206 6103-6106 Gene denotes ACE Gene:1636
207 6250-6253 Gene denotes ACE Gene:1636
208 6292-6296 Gene denotes ACE2 Gene:59272
209 6482-6485 Gene denotes ACE Gene:1636
210 6666-6670 Gene denotes ACE2 Gene:59272
211 6691-6695 Gene denotes ACE2 Gene:59272
212 6923-6927 Gene denotes ACE2 Gene:59272
213 6983-6986 Gene denotes ACE Gene:1636
214 7123-7127 Gene denotes ACE2 Gene:59272
215 7305-7308 Gene denotes ACE Gene:1636
216 7427-7430 Gene denotes ACE Gene:1636
217 7507-7511 Gene denotes ACE2 Gene:59272
218 7666-7670 Gene denotes ACE2 Gene:59272
219 6306-6320 Gene denotes angiotensin II Gene:183
220 5987-5993 Species denotes humans Tax:9606
221 6121-6129 Species denotes patients Tax:9606
222 6370-6378 Species denotes patients Tax:9606
223 6706-6714 Species denotes patients Tax:9606
224 6812-6820 Species denotes patients Tax:9606
225 6958-6966 Species denotes patients Tax:9606
226 7027-7035 Species denotes patients Tax:9606
227 7087-7095 Species denotes patients Tax:9606
228 7153-7161 Species denotes patients Tax:9606
229 7248-7256 Species denotes patients Tax:9606
230 6496-6505 Chemical denotes captopril MESH:D002216
231 6533-6542 Chemical denotes captopril MESH:D002216
232 7208-7218 Chemical denotes olmesartan MESH:C437965
233 7309-7318 Chemical denotes inhibitor
234 7319-7328 Chemical denotes enalapril MESH:D004656
235 7349-7357 Chemical denotes losartan MESH:D019808
236 7359-7370 Chemical denotes candesartan MESH:C081643
237 7372-7381 Chemical denotes valsartan MESH:D000068756
238 7387-7398 Chemical denotes telmisartan MESH:D000077333
239 6135-6158 Disease denotes coronary artery disease MESH:D003324
240 6384-6396 Disease denotes hypertension MESH:D006973
241 6826-6839 Disease denotes heart failure MESH:D006333
242 6843-6862 Disease denotes atrial fibrillation MESH:D001281
243 6866-6881 Disease denotes aortic stenosis MESH:D001024
244 6889-6912 Disease denotes coronary artery disease MESH:D003324
245 7101-7113 Disease denotes hypertension MESH:D006973
259 7925-7929 Gene denotes ACE2 Gene:59272
260 8091-8095 Gene denotes ACE2 Gene:59272
261 8206-8210 Gene denotes ACE2 Gene:59272
262 8385-8389 Gene denotes ACE2 Gene:59272
263 8482-8485 Gene denotes ACE Gene:1636
264 8561-8565 Gene denotes ACE2 Gene:59272
265 8667-8671 Gene denotes ACE2 Gene:59272
266 8843-8848 Gene denotes spike Gene:43740568
267 7870-7875 Species denotes human Tax:9606
268 8603-8609 Species denotes humans Tax:9606
269 8832-8842 Species denotes SARS-CoV-2 Tax:2697049
270 8889-8895 Species denotes humans Tax:9606
271 8953-8963 Species denotes SARS-CoV-2 Tax:2697049
273 9046-9054 Disease denotes Covid-19 MESH:C000657245
306 9113-9117 Gene denotes ACE2 Gene:59272
307 9157-9161 Gene denotes ACE2 Gene:59272
308 9293-9307 Gene denotes angiotensin II Gene:183
309 9422-9427 Gene denotes spike Gene:43740568
310 9476-9480 Gene denotes ACE2 Gene:59272
311 9584-9588 Gene denotes ACE2 Gene:59272
312 9659-9663 Gene denotes ACE2 Gene:59272
313 9799-9813 Gene denotes angiotensin II Gene:183
314 9915-9920 Gene denotes spike Gene:43740568
315 10049-10053 Gene denotes ACE2 Gene:70008
316 10259-10273 Gene denotes angiotensin II Gene:183
317 10371-10375 Gene denotes ACE2 Gene:59272
318 10418-10422 Gene denotes ACE2 Gene:59272
319 10552-10566 Gene denotes angiotensin II Gene:183
320 9055-9065 Species denotes SARS-CoV-2 Tax:2697049
321 9411-9421 Species denotes SARS-CoV-2 Tax:2697049
322 9878-9883 Species denotes mouse Tax:10090
323 9904-9912 Species denotes SARS-CoV Tax:694009
324 9999-10004 Species denotes mouse Tax:10090
325 10144-10171 Species denotes respiratory syncytial virus Tax:12814
326 10193-10201 Species denotes patients Tax:9606
327 10643-10649 Species denotes humans Tax:9606
328 9348-9360 Disease denotes organ injury MESH:D009102
329 9364-9372 Disease denotes Covid-19 MESH:C000657245
330 9521-9536 Disease denotes viral infection MESH:D001102
331 9943-9954 Disease denotes lung injury MESH:D055370
332 10066-10083 Disease denotes acute lung injury MESH:D055371
333 10207-10215 Disease denotes Covid-19 MESH:C000657245
334 10341-10352 Disease denotes lung injury MESH:D055370
335 10460-10471 Disease denotes lung-injury MESH:D055370
336 10511-10527 Disease denotes viral infections MESH:D001102
337 10604-10639 Disease denotes acute respiratory distress syndrome MESH:D012128
362 10666-10670 Gene denotes ACE2 Gene:59272
363 11135-11139 Gene denotes ACE2 Gene:59272
364 11225-11229 Gene denotes ACE2 Gene:59272
365 11345-11359 Gene denotes angiotensin II Gene:183
366 11505-11509 Gene denotes ACE2 Gene:59272
367 11562-11566 Gene denotes ACE2 Gene:59272
368 11578-11592 Gene denotes angiotensin II Gene:183
369 11740-11744 Gene denotes ACE2 Gene:59272
370 11379-11387 Species denotes patients Tax:9606
371 11603-11608 Species denotes human Tax:9606
372 11987-11995 Species denotes patients Tax:9606
373 11924-11932 Chemical denotes losartan MESH:D019808
374 10806-10814 Disease denotes Covid-19 MESH:C000657245
375 10827-10844 Disease denotes myocardial injury MESH:D009202
376 10905-10913 Disease denotes Covid-19 MESH:C000657245
377 10982-10987 Disease denotes death MESH:D003643
378 11044-11055 Disease denotes myocarditis MESH:D009205
379 11076-11083 Disease denotes viremia MESH:D014766
380 11284-11306 Disease denotes ventricular remodeling MESH:D020257
381 11322-11334 Disease denotes acute injury MESH:D000208
382 11392-11396 Disease denotes died MESH:D003643
383 11631-11653 Disease denotes dilated cardiomyopathy MESH:D002311
384 11839-11851 Disease denotes organ injury MESH:D009102
385 11952-11960 Disease denotes Covid-19 MESH:C000657245
387 12194-12202 Disease denotes Covid-19 MESH:C000657245
399 12289-12293 Gene denotes ACE2 Gene:59272
400 12327-12337 Species denotes SARS-CoV-2 Tax:2697049
401 12421-12429 Species denotes patients Tax:9606
402 12496-12504 Species denotes patients Tax:9606
403 12568-12576 Species denotes patients Tax:9606
404 12845-12853 Species denotes patients Tax:9606
405 12461-12469 Disease denotes Covid-19 MESH:C000657245
406 12521-12544 Disease denotes cardiovascular diseases MESH:D002318
407 12585-12602 Disease denotes myocardial injury MESH:D009202
408 12615-12632 Disease denotes myocardial stress MESH:D000079225
409 12640-12654 Disease denotes cardiomyopathy MESH:D009202
428 13017-13025 Species denotes patients Tax:9606
429 13127-13135 Species denotes patients Tax:9606
430 13297-13305 Species denotes patients Tax:9606
431 13703-13711 Species denotes patients Tax:9606
432 13090-13099 Chemical denotes Quinapril MESH:D000077583
433 13190-13199 Chemical denotes quinapril MESH:D000077583
434 12873-12886 Disease denotes heart failure MESH:D006333
435 12982-12995 Disease denotes heart failure MESH:D006333
436 13002-13016 Disease denotes critically ill MESH:D016638
437 13031-13039 Disease denotes Covid-19 MESH:C000657245
438 13161-13174 Disease denotes heart failure MESH:D006333
439 13263-13270 Disease denotes TRED-HF
440 13311-13324 Disease denotes heart failure MESH:D006333
441 13474-13496 Disease denotes dilated cardiomyopathy MESH:D002311
442 13564-13585 Disease denotes myocardial infarction MESH:D009203
443 13684-13693 Disease denotes mortality MESH:D003643
444 13743-13760 Disease denotes myocardial injury MESH:D009202
445 13777-13785 Disease denotes Covid-19 MESH:C000657245
451 14237-14244 Species denotes patient Tax:9606
452 14432-14439 Species denotes patient Tax:9606
453 14655-14663 Species denotes patients Tax:9606
454 13936-13948 Disease denotes hypertension MESH:D006973
455 14669-14677 Disease denotes Covid-19 MESH:C000657245
466 14945-14953 Species denotes patients Tax:9606
467 15069-15077 Species denotes patients Tax:9606
468 15158-15166 Species denotes patients Tax:9606
469 15242-15250 Species denotes patients Tax:9606
470 15339-15347 Species denotes patients Tax:9606
471 14959-14981 Disease denotes chronic kidney disease MESH:D051436
472 15018-15032 Disease denotes kidney disease MESH:D007674
473 15083-15091 Disease denotes Covid-19 MESH:C000657245
474 15175-15189 Disease denotes critically ill MESH:D016638
475 15275-15294 Disease denotes acute kidney injury MESH:D058186
482 15671-15675 Gene denotes ACE2 Gene:59272
483 15805-15813 Species denotes patients Tax:9606
484 16063-16071 Species denotes patients Tax:9606
485 15756-15764 Disease denotes Covid-19 MESH:C000657245
486 15898-15906 Disease denotes Covid-19 MESH:C000657245
487 16077-16085 Disease denotes Covid-19 MESH:C000657245
490 16369-16380 Chemical denotes Aldosterone MESH:D000450
491 16334-16342 Disease denotes Covid-19 MESH:C000657245
495 16390-16394 Gene denotes ACE2 Gene:59272
496 16483-16493 Species denotes SARS-CoV-2 Tax:2697049
497 16525-16533 Disease denotes Covid-19 MESH:C000657245
501 16621-16625 Gene denotes ACE2 Gene:59272
502 16681-16689 Species denotes patients Tax:9606
503 16695-16703 Disease denotes Covid-19 MESH:C000657245
506 16799-16805 Species denotes humans Tax:9606
507 16871-16879 Disease denotes Covid-19 MESH:C000657245
512 16992-16996 Gene denotes ACE2 Gene:59272
513 16986-16991 Species denotes human Tax:9606
514 17009-17017 Chemical denotes losartan MESH:D019808
515 17021-17029 Disease denotes Covid-19 MESH:C000657245
519 17082-17090 Species denotes patients Tax:9606
520 17117-17130 Disease denotes heart failure MESH:D006333
521 17143-17164 Disease denotes myocardial infarction MESH:D009203
524 17318-17326 Species denotes patients Tax:9606
525 17407-17415 Disease denotes Covid-19 MESH:C000657245
966 17727-17737 Species denotes SARS-CoV-2 Tax:2697049
967 17764-17775 Chemical denotes Aldosterone MESH:D000450
978 17960-17991 Gene denotes angiotensin-converting enzyme 2 Gene:59272
979 17993-17997 Gene denotes ACE2 Gene:59272
980 18048-18052 Gene denotes ACE2 Gene:59272
981 18103-18117 Gene denotes angiotensin II Gene:183
982 18245-18248 Gene denotes ACE Gene:1636
983 18257-18286 Gene denotes angiotensin-converting enzyme Gene:1636
984 17814-17861 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
985 17863-17873 Species denotes SARS-CoV-2 Tax:2697049
986 18174-18185 Chemical denotes aldosterone MESH:D000450
987 18205-18216 Disease denotes lung injury MESH:D055370

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 1627-1631 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T2 2101-2109 Body_part denotes Appendix http://purl.org/sig/ont/fma/fma14542
T3 4184-4190 Body_part denotes Tissue http://purl.org/sig/ont/fma/fma9637
T4 4706-4712 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T5 4796-4801 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T6 4806-4813 Body_part denotes kidneys http://purl.org/sig/ont/fma/fma7203
T7 4850-4855 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T8 4910-4914 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T9 4915-4940 Body_part denotes alveolar epithelial cells http://purl.org/sig/ont/fma/fma62499
T10 4935-4940 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T11 5043-5048 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T12 5666-5672 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T13 5821-5834 Body_part denotes messenger RNA http://purl.org/sig/ont/fma/fma67122
T14 5831-5834 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T15 5849-5856 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T16 6135-6150 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T17 6659-6665 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T18 6826-6831 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T19 6889-6904 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T20 6916-6922 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T21 7472-7482 Body_part denotes intestinal http://purl.org/sig/ont/fma/fma7199
T22 7483-7496 Body_part denotes messenger RNA http://purl.org/sig/ont/fma/fma67122
T23 7493-7496 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T24 7638-7642 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T25 8084-8090 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T26 8412-8418 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T27 8533-8537 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T28 8711-8717 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T29 8849-8856 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T30 9348-9353 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T31 9428-9435 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T32 9494-9507 Body_part denotes cell surfaces http://purl.org/sig/ont/fma/fma67653
T33 9494-9498 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T34 9631-9636 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T35 9680-9685 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T36 9710-9720 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T37 9921-9928 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T38 9943-9947 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T39 10072-10076 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T40 10252-10258 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T41 10341-10345 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T42 10460-10464 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T43 11415-11420 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T44 11458-11461 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T45 11510-11517 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T46 11745-11752 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T47 11839-11844 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T48 12755-12761 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T49 12766-12776 Body_part denotes myocardium http://purl.org/sig/ont/fma/fma9462
T50 12873-12878 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T51 12982-12987 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T52 13100-13105 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T53 13161-13166 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T54 13311-13316 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T55 14305-14310 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T56 14489-14494 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T57 14781-14786 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T58 14967-14973 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T59 15018-15024 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T60 15281-15287 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T61 17117-17122 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T62 17595-17603 Body_part denotes Appendix http://purl.org/sig/ont/fma/fma14542
T63 17880-17885 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T64 17905-17916 Body_part denotes pneumocytes http://purl.org/sig/ont/fma/fma62499
T65 18205-18209 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1627-1631 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T2 4184-4190 Body_part denotes Tissue http://purl.obolibrary.org/obo/UBERON_0000479
T3 4706-4712 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T4 4729-4735 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T5 4796-4801 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T6 4910-4914 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T7 5666-5672 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T8 6135-6150 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T9 6144-6150 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T10 6826-6831 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T11 6889-6904 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T12 6898-6904 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T13 7638-7642 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T14 8412-8418 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T15 8533-8537 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T16 8711-8717 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T17 9235-9241 Body_part denotes organs http://purl.obolibrary.org/obo/UBERON_0000062
T18 9348-9353 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T19 9943-9947 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T20 10072-10076 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T21 10341-10345 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T22 10460-10464 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T23 11415-11420 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T24 11839-11844 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T25 12755-12761 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T26 12766-12776 Body_part denotes myocardium http://purl.obolibrary.org/obo/UBERON_0002349
T27 12873-12878 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T28 12982-12987 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T29 13100-13105 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T30 13161-13166 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T31 13311-13316 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T32 14305-14310 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T33 14489-14494 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T34 14781-14786 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T35 14967-14973 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T36 15018-15024 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T37 15281-15287 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T38 17117-17122 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T39 18205-18209 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid_AGAC

Id Subject Object Predicate Lexical cue
p78790s67 5812-5820 PosReg denotes increase
p78790s68 5821-5845 MPA denotes messenger RNA expression
p78790s72 5849-5863 MPA denotes protein levels
p78796s8 7462-7471 PosReg denotes increased
p78796s9 7472-7482 CPA denotes intestinal
p78796s10 7483-7503 MPA denotes messenger RNA levels
p78808s39 9476-9480 Protein denotes ACE2
p78808s53 9567-9574 NegReg denotes reduced
p78808s56 9589-9599 MPA denotes expression
p78811s9 10233-10241 PosReg denotes elevated
p78811s14 10271-10273 MPA denotes II
p78816s27 11497-11504 NegReg denotes reduced
p78816s28 11505-11517 Protein denotes ACE2 protein
p78816s30 11518-11528 MPA denotes expression
p78841s8 16612-16620 PosReg denotes increase
p78841s9 16621-16625 Protein denotes ACE2
p78841s10 16626-16636 MPA denotes expression
p78855s7 18040-18052 MPA denotes surface ACE2
p78855s17 18093-18117 MPA denotes unopposed angiotensin II
p78855s20 18118-18130 PosReg denotes accumulation

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 220-253 Disease denotes Severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T2 269-277 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T3 285-293 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T4 333-337 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T5 387-411 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T6 617-621 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T7 662-666 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T8 1632-1638 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T9 1925-1937 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T10 2170-2182 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T11 2358-2370 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T12 2484-2496 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T13 3280-3292 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T14 3630-3642 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T15 4860-4868 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T16 4897-4903 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T17 6135-6158 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T18 6144-6158 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T19 6384-6396 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T20 6826-6839 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T21 6843-6862 Disease denotes atrial fibrillation http://purl.obolibrary.org/obo/MONDO_0004981
T22 6866-6881 Disease denotes aortic stenosis http://purl.obolibrary.org/obo/MONDO_0004978|http://purl.obolibrary.org/obo/MONDO_0042981
T24 6889-6912 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T25 6898-6912 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T26 7101-7113 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T27 7204-7207 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T28 8832-8840 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T29 8953-8961 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T30 9055-9063 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T31 9354-9360 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T32 9411-9419 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T33 9521-9536 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T34 9527-9536 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T35 9904-9912 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T36 9937-9954 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T38 9948-9954 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T39 10066-10083 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T41 10077-10083 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T42 10346-10352 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T43 10465-10471 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T44 10604-10639 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T45 10610-10639 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T46 10838-10844 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T47 11038-11055 Disease denotes viral myocarditis http://purl.obolibrary.org/obo/MONDO_0023161
T48 11044-11055 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T49 11116-11126 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T50 11194-11200 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T51 11328-11334 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T52 11402-11406 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T53 11631-11653 Disease denotes dilated cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0005021
T54 11639-11653 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T55 11845-11851 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T56 12327-12335 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T57 12521-12544 Disease denotes cardiovascular diseases http://purl.obolibrary.org/obo/MONDO_0004995
T58 12596-12602 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T59 12873-12886 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T60 12982-12995 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T61 13100-13113 Disease denotes Heart Failure http://purl.obolibrary.org/obo/MONDO_0005252
T62 13149-13174 Disease denotes symptomatic heart failure http://purl.obolibrary.org/obo/MONDO_0005254
T63 13161-13174 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T64 13311-13324 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T65 13474-13496 Disease denotes dilated cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0005021
T66 13482-13496 Disease denotes cardiomyopathy http://purl.obolibrary.org/obo/MONDO_0004994
T67 13564-13585 Disease denotes myocardial infarction http://purl.obolibrary.org/obo/MONDO_0005068
T68 13754-13760 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T69 13936-13948 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T70 14292-14319 Disease denotes increases in blood pressure http://purl.obolibrary.org/obo/MONDO_0005044
T71 14959-14981 Disease denotes chronic kidney disease http://purl.obolibrary.org/obo/MONDO_0005300
T72 14967-14981 Disease denotes kidney disease http://purl.obolibrary.org/obo/MONDO_0001343|http://purl.obolibrary.org/obo/MONDO_0005240
T74 15010-15032 Disease denotes chronic kidney disease http://purl.obolibrary.org/obo/MONDO_0005300
T75 15018-15032 Disease denotes kidney disease http://purl.obolibrary.org/obo/MONDO_0001343|http://purl.obolibrary.org/obo/MONDO_0005240
T77 15275-15294 Disease denotes acute kidney injury http://purl.obolibrary.org/obo/MONDO_0002492
T78 15288-15294 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T79 16483-16491 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T80 17005-17008 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T81 17117-17130 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T82 17143-17164 Disease denotes myocardial infarction http://purl.obolibrary.org/obo/MONDO_0005068
T83 17727-17735 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T84 17814-17861 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T85 17814-17847 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T86 17863-17871 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T87 18210-18216 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T88 18292-18295 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 159-167 http://purl.obolibrary.org/obo/PR_000018263 denotes peptides
T2 202-207 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T3 564-574 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T4 597-598 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 622-629 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T6 667-674 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T7 684-687 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T8 705-706 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 1343-1349 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T10 1501-1509 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T11 1513-1519 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T12 1627-1631 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T13 1627-1631 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T14 2077-2079 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T15 3535-3537 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T16 3811-3812 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T17 4177-4183 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes Humans
T18 4247-4248 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T19 4314-4322 http://purl.obolibrary.org/obo/PR_000018263 denotes peptides
T20 4343-4344 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 4672-4680 http://purl.obolibrary.org/obo/PR_000018263 denotes peptides
T22 4698-4704 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T23 4729-4735 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T24 4796-4801 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T25 4796-4801 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T26 4796-4801 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T27 4796-4801 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T28 4806-4813 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidneys
T29 4806-4813 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidneys
T30 4806-4813 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidneys
T31 4850-4855 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T32 4910-4914 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T33 4910-4914 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T34 4924-4934 http://purl.obolibrary.org/obo/CL_0000066 denotes epithelial
T35 4935-4940 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T36 5043-5048 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T37 5312-5320 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T38 5426-5432 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T39 5456-5457 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T40 5525-5533 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T41 5550-5556 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T42 5654-5662 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T43 5690-5696 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T44 5887-5889 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T45 5947-5953 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T46 5987-5993 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T47 6144-6150 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T48 6144-6150 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T49 6207-6208 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T50 6332-6334 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T51 6560-6561 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T52 6617-6619 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T53 6659-6665 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T54 6671-6679 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T55 6826-6831 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T56 6826-6831 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T57 6826-6831 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T58 6826-6831 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T59 6866-6872 http://www.ebi.ac.uk/efo/EFO_0000265 denotes aortic
T60 6898-6904 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T61 6898-6904 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T62 6916-6922 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T63 6928-6936 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T64 7040-7041 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T65 7400-7402 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T66 7472-7482 http://purl.obolibrary.org/obo/UBERON_0000160 denotes intestinal
T67 7472-7482 http://www.ebi.ac.uk/efo/EFO_0000834 denotes intestinal
T68 7638-7642 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T69 7638-7642 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T70 7870-7875 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T71 8029-8030 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 8048-8050 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T73 8084-8090 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T74 8113-8114 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T75 8141-8149 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T76 8169-8177 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T77 8228-8236 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T78 8238-8239 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T79 8533-8537 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T80 8533-8537 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T81 8582-8588 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T82 8603-8609 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T83 8682-8690 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T84 8889-8895 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T85 9235-9241 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organs
T86 9246-9249 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T87 9308-9316 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T88 9348-9353 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T89 9494-9498 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T90 9508-9510 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T91 9575-9583 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T92 9622-9636 http://purl.obolibrary.org/obo/CL_0000010 denotes cultured cells
T93 9664-9672 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T94 9680-9685 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T95 9842-9852 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T96 9878-9883 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T97 9943-9947 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T98 9943-9947 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T99 9990-9992 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T100 9999-10004 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T101 10072-10076 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T102 10072-10076 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T103 10166-10171 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T104 10178-10179 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T105 10252-10258 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T106 10341-10345 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T107 10341-10345 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T108 10460-10464 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T109 10460-10464 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T110 10577-10578 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T111 10643-10649 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T112 10996-11003 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T113 11100-11101 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T114 11140-11143 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T115 11144-11145 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T116 11242-11248 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T117 11408-11410 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T118 11415-11420 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T119 11415-11420 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T120 11415-11420 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T121 11415-11420 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T122 11603-11608 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T123 11619-11625 http://purl.obolibrary.org/obo/UBERON_0000948 denotes hearts
T124 11619-11625 http://purl.obolibrary.org/obo/UBERON_0007100 denotes hearts
T125 11619-11625 http://purl.obolibrary.org/obo/UBERON_0015228 denotes hearts
T126 11619-11625 http://www.ebi.ac.uk/efo/EFO_0000815 denotes hearts
T127 11698-11702 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T128 11839-11844 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T129 11936-11937 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T130 12044-12045 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T131 12578-12584 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T132 12755-12761 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T133 12755-12761 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T134 12755-12761 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T135 12766-12776 http://purl.obolibrary.org/obo/UBERON_0002349 denotes myocardium
T136 12873-12878 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T137 12873-12878 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T138 12873-12878 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T139 12873-12878 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T140 12982-12987 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T141 12982-12987 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T142 12982-12987 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T143 12982-12987 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T144 13100-13105 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T145 13100-13105 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T146 13100-13105 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T147 13100-13105 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T148 13161-13166 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T149 13161-13166 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T150 13161-13166 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T151 13161-13166 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T152 13212-13213 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T153 13311-13316 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T154 13311-13316 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T155 13311-13316 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T156 13311-13316 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T157 13533-13534 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T158 13653-13656 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T159 14161-14162 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T160 14217-14218 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T161 14305-14310 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T162 14305-14310 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T163 14489-14494 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T164 14489-14494 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T165 14522-14523 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T166 14706-14707 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T167 14722-14732 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T168 14781-14786 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T169 14781-14786 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T170 14967-14973 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T171 14967-14973 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T172 14967-14973 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T173 15018-15024 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T174 15018-15024 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T175 15018-15024 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T176 15118-15120 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1
T177 15281-15287 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T178 15281-15287 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T179 15281-15287 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T180 15923-15924 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T181 15987-15989 http://purl.obolibrary.org/obo/CLO_0008922 denotes S2
T182 15987-15989 http://purl.obolibrary.org/obo/CLO_0050052 denotes S2
T183 16441-16451 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T184 16499-16504 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T185 16799-16805 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T186 16915-16919 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T187 16986-16991 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T188 17117-17122 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T189 17117-17122 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T190 17117-17122 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T191 17117-17122 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T192 17880-17885 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T193 18138-18148 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T194 18205-18209 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T195 18205-18209 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 6-17 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T2 18-29 Chemical denotes Aldosterone http://purl.obolibrary.org/obo/CHEBI_27584
T3 85-96 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T4 97-108 Chemical denotes aldosterone http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834
T6 159-167 Chemical denotes peptides http://purl.obolibrary.org/obo/CHEBI_16670
T7 479-490 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T8 794-804 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T9 1046-1060 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T10 1050-1060 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T11 1065-1076 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T12 1191-1205 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T13 1195-1205 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T14 1255-1260 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T15 1701-1711 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T16 2837-2847 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T17 3470-3480 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T18 3664-3680 Chemical denotes antihypertensive http://purl.obolibrary.org/obo/CHEBI_35674
T19 3695-3705 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T20 3926-3936 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T21 3975-3985 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T22 4314-4322 Chemical denotes peptides http://purl.obolibrary.org/obo/CHEBI_16670
T23 4388-4402 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T26 4388-4399 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T27 4400-4402 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T28 4406-4417 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T29 4478-4484 Chemical denotes sodium http://purl.obolibrary.org/obo/CHEBI_26708
T30 4519-4533 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T33 4519-4530 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T34 4531-4533 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T35 4593-4604 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T36 4610-4621 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T37 4672-4680 Chemical denotes peptides http://purl.obolibrary.org/obo/CHEBI_16670
T38 5168-5182 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T39 5172-5182 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T40 5218-5232 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T43 5218-5229 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T44 5230-5232 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T45 5466-5480 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T46 5470-5480 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T47 5621-5635 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T48 5625-5635 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T49 5821-5834 Chemical denotes messenger RNA http://purl.obolibrary.org/obo/CHEBI_33699
T50 5849-5856 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T51 6103-6117 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T52 6107-6117 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T53 6177-6188 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T54 6250-6264 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T55 6254-6264 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T56 6306-6320 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T59 6306-6317 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T60 6318-6320 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T61 6398-6409 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T62 6482-6495 Chemical denotes ACE inhibitor http://purl.obolibrary.org/obo/CHEBI_35457
T63 6486-6495 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T64 6496-6505 Chemical denotes captopril http://purl.obolibrary.org/obo/CHEBI_3380
T65 6533-6542 Chemical denotes captopril http://purl.obolibrary.org/obo/CHEBI_3380
T66 6582-6593 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T67 6763-6773 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T68 6983-6997 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T69 6987-6997 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T70 7208-7218 Chemical denotes olmesartan http://purl.obolibrary.org/obo/CHEBI_48416
T71 7305-7318 Chemical denotes ACE inhibitor http://purl.obolibrary.org/obo/CHEBI_35457
T72 7309-7318 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T73 7319-7328 Chemical denotes enalapril http://purl.obolibrary.org/obo/CHEBI_4784
T74 7349-7357 Chemical denotes losartan http://purl.obolibrary.org/obo/CHEBI_6541
T75 7359-7370 Chemical denotes candesartan http://purl.obolibrary.org/obo/CHEBI_3347
T76 7372-7381 Chemical denotes valsartan http://purl.obolibrary.org/obo/CHEBI_9927
T77 7387-7398 Chemical denotes telmisartan http://purl.obolibrary.org/obo/CHEBI_9434
T78 7427-7441 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T79 7431-7441 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T80 7483-7496 Chemical denotes messenger RNA http://purl.obolibrary.org/obo/CHEBI_33699
T81 7624-7634 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T82 7978-7988 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T83 8037-8041 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T84 8124-8133 Chemical denotes indicator http://purl.obolibrary.org/obo/CHEBI_47867
T85 8305-8314 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T86 8482-8496 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T87 8486-8496 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T88 8519-8529 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T89 8649-8659 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T90 8849-8856 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T91 9293-9307 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T94 9293-9304 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T95 9305-9307 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T96 9428-9435 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T97 9799-9813 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T100 9799-9810 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T101 9811-9813 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T102 9921-9928 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T103 10259-10273 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T106 10259-10270 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T107 10271-10273 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T108 10552-10566 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T111 10552-10563 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T112 10564-10566 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T113 11345-11359 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T116 11345-11356 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T117 11357-11359 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T118 11510-11517 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T119 11578-11592 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T122 11578-11589 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T123 11590-11592 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T124 11745-11752 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T125 11924-11932 Chemical denotes losartan http://purl.obolibrary.org/obo/CHEBI_6541
T126 12051-12060 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T127 12407-12417 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T128 12700-12710 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T129 13090-13099 Chemical denotes Quinapril http://purl.obolibrary.org/obo/CHEBI_8713
T130 13190-13199 Chemical denotes quinapril http://purl.obolibrary.org/obo/CHEBI_8713
T131 13268-13270 Chemical denotes HF http://purl.obolibrary.org/obo/CHEBI_141438|http://purl.obolibrary.org/obo/CHEBI_29228
T133 13433-13443 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T134 13518-13528 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T135 13844-13854 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T136 13875-13885 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T137 13991-14001 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T138 14168-14177 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T139 14189-14205 Chemical denotes antihypertensive http://purl.obolibrary.org/obo/CHEBI_35674
T140 14363-14379 Chemical denotes antihypertensive http://purl.obolibrary.org/obo/CHEBI_35674
T141 14890-14900 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T142 15418-15428 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T143 15657-15667 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T144 15703-15708 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T145 15771-15781 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T146 15987-15989 Chemical denotes S2 http://purl.obolibrary.org/obo/CHEBI_29387
T147 16357-16368 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T148 16369-16380 Chemical denotes Aldosterone http://purl.obolibrary.org/obo/CHEBI_27584
T149 16597-16607 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T150 16857-16867 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T151 17009-17017 Chemical denotes losartan http://purl.obolibrary.org/obo/CHEBI_6541
T152 17058-17068 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T153 17284-17294 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T154 17752-17763 Chemical denotes Angiotensin http://purl.obolibrary.org/obo/CHEBI_2719
T155 17764-17775 Chemical denotes Aldosterone http://purl.obolibrary.org/obo/CHEBI_27584
T156 17902-17904 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T157 17960-17971 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T158 18103-18117 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T161 18103-18114 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T162 18115-18117 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T163 18162-18173 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T164 18174-18185 Chemical denotes aldosterone http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834
T166 18257-18268 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T167 18296-18307 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 905-914 http://purl.obolibrary.org/obo/GO_0016032 denotes virulence
T2 905-914 http://purl.obolibrary.org/obo/GO_0009405 denotes virulence
T3 4460-4476 http://purl.obolibrary.org/obo/GO_0042310 denotes vasoconstriction
T4 4485-4494 http://purl.obolibrary.org/obo/GO_0051235 denotes retention
T5 6321-6331 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T6 9462-9472 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T7 9521-9536 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T8 9645-9655 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T9 12275-12285 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T10 18006-18017 http://purl.obolibrary.org/obo/GO_0006897 denotes endocytosis

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 1925-1937 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T2 2170-2182 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T3 2358-2370 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T4 2484-2496 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T5 3280-3292 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T6 3630-3642 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T7 6384-6396 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T8 6826-6839 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T9 6843-6862 Phenotype denotes atrial fibrillation http://purl.obolibrary.org/obo/HP_0005110
T10 6866-6881 Phenotype denotes aortic stenosis http://purl.obolibrary.org/obo/HP_0001650
T11 7101-7113 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T12 9937-9954 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T13 10066-10083 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T14 10610-10630 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T15 11044-11055 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819
T16 11076-11083 Phenotype denotes viremia http://purl.obolibrary.org/obo/HP_0020071
T17 11631-11653 Phenotype denotes dilated cardiomyopathy http://purl.obolibrary.org/obo/HP_0001644
T18 12521-12544 Phenotype denotes cardiovascular diseases http://purl.obolibrary.org/obo/HP_0001626
T19 12873-12886 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T20 12982-12995 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T21 13100-13113 Phenotype denotes Heart Failure http://purl.obolibrary.org/obo/HP_0001635
T22 13161-13174 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T23 13311-13324 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T24 13474-13496 Phenotype denotes dilated cardiomyopathy http://purl.obolibrary.org/obo/HP_0001644
T25 13564-13585 Phenotype denotes myocardial infarction http://purl.obolibrary.org/obo/HP_0001658
T26 13936-13948 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T27 14292-14319 Phenotype denotes increases in blood pressure http://purl.obolibrary.org/obo/HP_0032263
T28 14959-14981 Phenotype denotes chronic kidney disease http://purl.obolibrary.org/obo/HP_0012622
T29 15010-15032 Phenotype denotes chronic kidney disease http://purl.obolibrary.org/obo/HP_0012622
T30 15275-15294 Phenotype denotes acute kidney injury http://purl.obolibrary.org/obo/HP_0001919
T31 17117-17130 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T32 17143-17164 Phenotype denotes myocardial infarction http://purl.obolibrary.org/obo/HP_0001658

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-73 Sentence denotes Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
T2 75-219 Sentence denotes The renin–angiotensin–aldosterone system (RAAS) is an elegant cascade of vasoactive peptides that orchestrate key processes in human physiology.
T3 220-1166 Sentence denotes Severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and SARS-CoV-2, which have been responsible for the SARS epidemic in 2002 to 2004 and for the more recent coronavirus disease 2019 (Covid-19) pandemic, respectively, interface with the RAAS through angiotensin-converting enzyme 2 (ACE2), an enzyme that physiologically counters RAAS activation but also functions as a receptor for both SARS viruses.1,2 The interaction between the SARS viruses and ACE2 has been proposed as a potential factor in their infectivity,3,4 and there are concerns about the use of RAAS inhibitors that may alter ACE2 and whether variation in ACE2 expression may be in part responsible for disease virulence in the ongoing Covid-19 pandemic.5-8 Indeed, some media sources and health systems have recently called for the discontinuation of ACE inhibitors and angiotensin-receptor blockers (ARBs), both prophylactically and in the context of suspected Covid-19.
T4 1167-1306 Sentence denotes Given the common use of ACE inhibitors and ARBs worldwide, guidance on the use of these drugs in patients with Covid-19 is urgently needed.
T5 1307-1417 Sentence denotes Here, we highlight that the data in humans are too limited to support or refute these hypotheses and concerns.
T6 1418-1639 Sentence denotes Specifically, we discuss the uncertain effects of RAAS blockers on ACE2 levels and activity in humans, and we propose an alternative hypothesis that ACE2 may be beneficial rather than harmful in patients with lung injury.
T7 1640-1790 Sentence denotes We also explicitly raise the concern that withdrawal of RAAS inhibitors may be harmful in certain high-risk patients with known or suspected Covid-19.
T8 1792-1844 Sentence denotes Covid-19 and Older Adults with Coexisting Conditions
T9 1845-1967 Sentence denotes Initial reports5-8 have called attention to the potential overrepresentation of hypertension among patients with Covid-19.
T10 1968-2450 Sentence denotes In the largest of several case series from China that have been released during the Covid-19 pandemic (Table S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org), hypertension was the most frequent coexisting condition in 1099 patients, with an estimated prevalence of 15%9; however, this estimate appears to be lower than the estimated prevalence of hypertension seen with other viral infections10 and in the general population in China.11,12
T11 2451-2735 Sentence denotes Coexisting conditions, including hypertension, have consistently been reported to be more common among patients with Covid-19 who have had severe illness, been admitted to the intensive care unit, received mechanical ventilation, or died than among patients who have had mild illness.
T12 2736-2910 Sentence denotes There are concerns that medical management of these coexisting conditions, including the use of RAAS inhibitors, may have contributed to the adverse health outcomes observed.
T13 2911-3217 Sentence denotes However, these conditions appear to track closely with advancing age,13 which is emerging as the strongest predictor of Covid-19–related death.14 Unfortunately, reports to date have not rigorously accounted for age or other key factors that contribute to health as potential confounders in risk prediction.
T14 3218-3387 Sentence denotes With other infective illnesses, coexisting conditions such as hypertension have been key prognostic determinants,10 and this also appears to be the case with Covid-19.15
T15 3388-3539 Sentence denotes It is important to note that, despite inferences about the use of background RAAS inhibitors, specific details have been lacking in studies (Table S1).
T16 3540-3937 Sentence denotes Population-based studies have estimated that only 30 to 40% of patients in China who have hypertension are treated with any antihypertensive therapy; RAAS inhibitors are used alone or in combination in 25 to 30% of these treated patients.11,12 Given such estimates, only a fraction of patients with Covid-19, at least in China, are anticipated to have been previously treated with RAAS inhibitors.
T17 3938-4127 Sentence denotes Data showing patterns of use of RAAS inhibitors and associated health outcomes that rigorously account for treatment indication and illness severity among patients with Covid-19 are needed.
T18 4129-4183 Sentence denotes Uncertain Effects of RAAS Inhibitors on ACE2 in Humans
T19 4184-4334 Sentence denotes Tissue-specific and circulating components of the RAAS make up a complex intersecting network of regulatory and counterregulatory peptides (Figure 1).
T20 4335-4509 Sentence denotes ACE2 is a key counterregulatory enzyme that degrades angiotensin II to angiotensin-(1–7), thereby attenuating its effects on vasoconstriction, sodium retention, and fibrosis.
T21 4510-5159 Sentence denotes Although angiotensin II is the primary substrate of ACE2, that enzyme also cleaves angiotensin I to angiotensin-(1–9) and participates in the hydrolysis of other peptides.16 In studies in humans, tissue samples from 15 organs have shown that ACE2 is expressed broadly, including in the heart and kidneys, as well as on the principal target cells for SARS-CoV-2 (and the site of dominant injury), the lung alveolar epithelial cells.17 Of interest, the circulating levels of soluble ACE2 are low and the functional role of ACE2 in the lungs appears to be relatively minimal under normal conditions18 but may be up-regulated in certain clinical states.
T22 5160-5350 Sentence denotes Because ACE inhibitors and ARBs have different effects on angiotensin II, the primary substrate of ACE2, the effects of these agents on ACE2 levels and activity may be anticipated to differ.
T23 5351-5452 Sentence denotes Despite substantial structural homology between ACE and ACE2, their enzyme active sites are distinct.
T24 5453-5921 Sentence denotes As a result, ACE inhibitors in clinical use do not directly affect ACE2 activity.19 Experimental animal models have shown mixed findings with respect to the effects of ACE inhibitors on ACE2 levels or activity in tissue.20-25 Similarly, animal models have had inconsistent findings with respect to the effects of ARBs on ACE2, with some showing that ARBs may increase messenger RNA expression or protein levels of ACE2 in tissue21,26-34 and others showing no effect.23
T25 5922-6054 Sentence denotes In contrast to available animal models, there are few studies in humans regarding the effects of RAAS inhibition on ACE2 expression.
T26 6055-6774 Sentence denotes In one study, the intravenous administration of ACE inhibitors in patients with coronary artery disease did not influence angiotensin-(1–7) production, a finding that calls into question whether ACE inhibitors have any direct effects on ACE2-directed angiotensin II metabolism.35 Similarly, in another study, among patients with hypertension, angiotensin-(1–7) levels appeared to be unaffected after initial treatment with the ACE inhibitor captopril; however, with exposure to captopril monotherapy over a period of 6 months, angiotensin-(1–7) levels increased.36 Furthermore, few studies have examined plasma ACE2 activity or urinary ACE2 levels in patients who have received long-term treatment with RAAS inhibitors.
T27 6775-7036 Sentence denotes In cross-sectional studies involving patients with heart failure,37 atrial fibrillation,38 aortic stenosis,39 and coronary artery disease,40 plasma ACE2 activity was not higher among patients who were taking ACE inhibitors or ARBs than among untreated patients.
T28 7037-7671 Sentence denotes In a longitudinal cohort study involving Japanese patients with hypertension, urinary ACE2 levels were higher among patients who received long-term treatment with the ARB olmesartan than among untreated control patients, but that association was not observed with the ACE inhibitor enalapril or with other ARBs (losartan, candesartan, valsartan, and telmisartan).41 Previous treatment with ACE inhibitors was associated with increased intestinal messenger RNA levels of ACE2 in one study, but that association was not observed with ARBs25; data are lacking regarding the effects of RAAS inhibitors on lung-specific expression of ACE2.
T29 7672-7887 Sentence denotes These seemingly conflicting data indicate the complexity underlying RAAS responses to pathway modulators and reinforce the concept that findings from preclinical models may not readily translate to human physiology.
T30 7888-8438 Sentence denotes Such data do suggest that effects on ACE2 should not be assumed to be uniform across RAAS inhibitors or even in response to therapies within a given drug class.41 It is important to note that the plasma ACE2 level may not be a reliable indicator of the activity of the full-length membrane-bound form, in part because ACE2 is shed from the membrane, a process that appears to be separately regulated by an endogenous inhibitor.42 In addition to the degree of expression, the biologic relevance of ACE2 may vary according to tissue and clinical state.
T31 8439-8622 Sentence denotes Unfortunately, data showing the effects of ACE inhibitors, ARBs, and other RAAS inhibitors on lung-specific expression of ACE2 in experimental animal models and in humans are lacking.
T32 8623-8857 Sentence denotes Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein.
T33 8858-8985 Sentence denotes Further mechanistic studies in humans are needed to better define the unique interplay between SARS-CoV-2 and the RAAS network.
T34 8987-9054 Sentence denotes Potential for Benefit Rather Than Harm of RAAS Blockers in Covid-19
T35 9055-9242 Sentence denotes SARS-CoV-2 appears not only to gain initial entry through ACE2 but also to subsequently down-regulate ACE2 expression such that the enzyme is unable to exert protective effects in organs.
T36 9243-9853 Sentence denotes It has been postulated but unproven that unabated angiotensin II activity may be in part responsible for organ injury in Covid-19.43,44 After the initial engagement of SARS-CoV-2 spike protein, there is subsequent down-regulation of ACE2 abundance on cell surfaces.45 Continued viral infection and replication contribute to reduced membrane ACE2 expression, at least in vitro in cultured cells.46 Down-regulation of ACE2 activity in the lungs facilitates the initial neutrophil infiltration in response to bacterial endotoxin47 and may result in unopposed angiotensin II accumulation and local RAAS activation.
T37 9854-10652 Sentence denotes Indeed, in experimental mouse models, exposure to SARS-CoV-1 spike protein induced acute lung injury, which is limited by RAAS blockade.45 Other mouse models have suggested that dysregulation of ACE2 may mediate acute lung injury that is secondary to virulent strains of influenza48,49 and respiratory syncytial virus.50 In a small study, patients with Covid-19 appeared to have elevated levels of plasma angiotensin II, which were in turn correlated with total viral load and degree of lung injury.44 Restoration of ACE2 through the administration of recombinant ACE2 appeared to reverse this devastating lung-injury process in preclinical models of other viral infections49,50 and safely reduced angiotensin II levels in a phase 2 trial evaluating acute respiratory distress syndrome in humans.51
T38 10653-10815 Sentence denotes Dysregulated ACE2 may theoretically also attenuate cardioprotection in the context of myocardial involvement and abnormal pulmonary hemodynamics52,53 in Covid-19.
T39 10816-11134 Sentence denotes Markers of myocardial injury have been shown to be elevated during the disease course of Covid-1954 and to increase rapidly with clinical deterioration and preceding death.14 Many viruses are cardiotropic, and subclinical viral myocarditis is commonly seen in viremia associated with a wide range of infectious agents.
T40 11135-11893 Sentence denotes ACE2 has a well-recognized role in myocardial recovery and injury response; in one study, ACE2 knockout in animal models contributed to adverse left ventricular remodeling in response to acute injury driven by angiotensin II.55 In autopsies of patients who died from SARS, 35% of heart samples showed the presence of viral RNA, which in turn was associated with reduced ACE2 protein expression.56 Administration of recombinant ACE2 normalizes angiotensin II levels in human explanted hearts with dilated cardiomyopathy.57 These hypotheses have prompted trials to test whether the provision of recombinant ACE2 protein may be beneficial in restoring balance to the RAAS network and potentially preventing organ injury (ClinicalTrials.gov number, NCT04287686).
T41 11894-12137 Sentence denotes In addition, paired trials of losartan as a treatment for Covid-19 are being conducted among patients who have not previously received treatment with a RAAS inhibitor and are either hospitalized (NCT04312009) or not hospitalized (NCT04311177).
T42 12139-12202 Sentence denotes Maintenance of RAAS Inhibitors with Known or Suspected Covid-19
T43 12203-12460 Sentence denotes Despite these theoretical uncertainties regarding whether pharmacologic regulation of ACE2 may influence the infectivity of SARS-CoV-2, there is clear potential for harm related to the withdrawal of RAAS inhibitors in patients in otherwise stable condition.
T44 12461-12694 Sentence denotes Covid-19 is particularly severe in patients with underlying cardiovascular diseases,9 and in many of these patients, active myocardial injury,14,54,58-60 myocardial stress,59 and cardiomyopathy59 develop during the course of illness.
T45 12695-12854 Sentence denotes RAAS inhibitors have established benefits in protecting the kidney and myocardium, and their withdrawal may risk clinical decompensation in high-risk patients.
T46 12855-13855 Sentence denotes Although rates of heart failure have been infrequently reported in epidemiologic reports from China to date, the prevalence of heart failure among critically ill patients with Covid-19 in the United States may be high (>40%).59 In the Quinapril Heart Failure Trial, among patients with chronic symptomatic heart failure, withdrawal of quinapril resulted in a progressive decline in clinical status.61 In the TRED-HF trial, among asymptomatic patients with heart failure with recovered left ventricular ejection fraction, the phased withdrawal of medical therapy (including RAAS inhibitors) resulted in rapid relapse of dilated cardiomyopathy.62 In addition, RAAS inhibitors are a cornerstone of therapy after myocardial infarction: maintenance of therapy in the days to weeks after the index event has been shown to reduce early mortality.63 Among patients with unstable clinical status, myocardial injury associated with Covid-19 may pose even higher early risks after withdrawal of RAAS inhibitors.
T47 13856-14145 Sentence denotes Withdrawal of RAAS inhibitors that are being administered for the management of hypertension may be less risky than withdrawal of RAAS inhibitors that are being administered for conditions in which they are considered guideline-directed therapy but may be associated with other challenges.
T48 14146-14320 Sentence denotes Switching from a RAAS inhibitor to another antihypertensive therapy in a stable ambulatory patient may require careful follow-up to avoid rebound increases in blood pressure.
T49 14321-14450 Sentence denotes In addition, selection of dose-equivalent antihypertensive therapies may be challenging in practice and may be patient-dependent.
T50 14451-14857 Sentence denotes Even small and short-lived periods of blood pressure instability after a therapeutic change have been associated with excess cardiovascular risk.64-66 This may be an especially important consideration in patients with Covid-19, which appears to result in a state of RAAS activation,44 and in settings (e.g., China) where baseline blood-pressure control is infrequently reached at the population level.11,12
T51 14858-14982 Sentence denotes The effects of withdrawing RAAS inhibitors or switching treatments are uncertain among patients with chronic kidney disease.
T52 14983-15523 Sentence denotes Although reported rates of chronic kidney disease appear to be low among hospitalized patients with Covid-19 in China (1 to 3%) (Table S1), the prevalence may be higher among patients who are critically ill and among those in other geographic regions.59 Many patients have varying degrees of acute kidney injury during illness.14,67,68 For these high-risk patients, individualized treatment decisions regarding the maintenance of RAAS inhibitors that are guided by hemodynamic status, renal function, and clinical stability are recommended.
T53 15524-15991 Sentence denotes On the basis of the available evidence, we think that, despite the theoretical concerns and uncertainty regarding the effect of RAAS inhibitors on ACE2 and the way in which these drugs might affect the propensity for or severity of Covid-19, RAAS inhibitors should be continued in patients in otherwise stable condition who are at risk for, are being evaluated for, or have Covid-19 (see text box), a position now supported by multiple specialty societies (Table S2).
T54 15992-16289 Sentence denotes Although additional data may further inform the treatment of high-risk patients with Covid-19, clinicians need to be cognizant of the unintended consequences of prematurely discontinuing proven therapies in response to hypothetical concerns that may be based on incomplete experimental evidence.69
T55 16290-16387 Sentence denotes Key Points Related to the Interplay between Covid-19 and the Renin–Angiotensin–Aldosterone System
T56 16388-16542 Sentence denotes • ACE2, an enzyme that physiologically counters RAAS activation, is the functional receptor to SARS-CoV-2, the virus responsible for the Covid-19 pandemic
T57 16543-16703 Sentence denotes • Select preclinical studies have suggested that RAAS inhibitors may increase ACE2 expression, raising concerns regarding their safety in patients with Covid-19
T58 16704-16879 Sentence denotes • Insufficient data are available to determine whether these observations readily translate to humans, and no studies have evaluated the effects of RAAS inhibitors in Covid-19
T59 16880-17029 Sentence denotes • Clinical trials are under way to test the safety and efficacy of RAAS modulators, including recombinant human ACE2 and the ARB losartan in Covid-19
T60 17030-17228 Sentence denotes • Abrupt withdrawal of RAAS inhibitors in high-risk patients, including those who have heart failure or have had myocardial infarction, may result in clinical instability and adverse health outcomes
T61 17229-17415 Sentence denotes • Until further data are available, we think that RAAS inhibitors should be continued in patients in otherwise stable condition who are at risk for, being evaluated for, or with Covid-19
T62 17417-17519 Sentence denotes Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
T63 17521-17579 Sentence denotes This article was published on March 30, 2020, at NEJM.org.
T64 17581-17603 Sentence denotes Supplementary Appendix
T65 17604-17640 Sentence denotes Click here for additional data file.
T66 17642-17658 Sentence denotes Disclosure Forms
T67 17659-17695 Sentence denotes Click here for additional data file.
T68 17697-17783 Sentence denotes Figure 1 Interaction between SARS-CoV-2 and the Renin–Angiotensin–Aldosterone System.
T69 17784-17999 Sentence denotes Shown is the initial entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into cells, primarily type II pneumocytes, after binding to its functional receptor, angiotensin-converting enzyme 2 (ACE2).
T70 18000-18131 Sentence denotes After endocytosis of the viral complex, surface ACE2 is further down-regulated, resulting in unopposed angiotensin II accumulation.
T71 18132-18244 Sentence denotes Local activation of the renin–angiotensin–aldosterone system may mediate lung injury responses to viral insults.
T72 18245-18325 Sentence denotes ACE denotes angiotensin-converting enzyme, and ARB angiotensin-receptor blocker.

2_test

Id Subject Object Predicate Lexical cue
32227760-32171062-75177404 1862-1863 32171062 denotes 8
32227760-31333767-75177405 2403-2405 31333767 denotes 10
32227760-29449338-75177406 2445-2447 29449338 denotes 11
32227760-29102084-75177407 2448-2450 29102084 denotes 12
32227760-32171076-75177408 3054-3056 32171076 denotes 14
32227760-31333767-75177409 3331-3333 31333767 denotes 10
32227760-32173574-75177410 3385-3387 32173574 denotes 15
32227760-29449338-75177411 3778-3780 29449338 denotes 11
32227760-29102084-75177412 3781-3783 29102084 denotes 12
32227760-11815627-75177413 4681-4683 11815627 denotes 16
32227760-15141377-75177414 4941-4943 15141377 denotes 17
32227760-31786979-75177415 5105-5107 31786979 denotes 18
32227760-15283675-75177416 5534-5536 15283675 denotes 19
32227760-18192334-75177417 5676-5678 18192334 denotes 25
32227760-15897343-75177418 5881-5883 15897343 denotes 21
32227760-19004932-75177419 5887-5889 19004932 denotes 34
32227760-22715807-75177420 5919-5921 22715807 denotes 23
32227760-15361769-75177421 6332-6334 15361769 denotes 35
32227760-8793704-75177422 6617-6619 8793704 denotes 36
32227760-19700132-75177423 6840-6842 19700132 denotes 37
32227760-27738071-75177424 6863-6865 27738071 denotes 38
32227760-31607667-75177425 6882-6884 31607667 denotes 39
32227760-29897923-75177426 6913-6915 29897923 denotes 40
32227760-24842388-75177427 7400-7402 24842388 denotes 41
32227760-25534429-75177428 7573-7575 25534429 denotes 25
32227760-24842388-75177429 8048-8050 24842388 denotes 41
32227760-15983030-75177430 8315-8317 15983030 denotes 42
32227760-32129518-75177431 9373-9375 32129518 denotes 43
32227760-32048163-75177432 9376-9378 32048163 denotes 44
32227760-16007097-75177433 9508-9510 16007097 denotes 45
32227760-22718567-75177434 9637-9639 22718567 denotes 46
32227760-28935640-75177435 9768-9770 28935640 denotes 47
32227760-16007097-75177436 9990-9992 16007097 denotes 45
32227760-25391767-75177437 10134-10136 25391767 denotes 48
32227760-24800825-75177438 10137-10139 24800825 denotes 49
32227760-26813885-75177439 10172-10174 26813885 denotes 50
32227760-32048163-75177440 10353-10355 32048163 denotes 44
32227760-24800825-75177441 10527-10529 24800825 denotes 49
32227760-26813885-75177442 10530-10532 26813885 denotes 50
32227760-28877748-75177443 10650-10652 28877748 denotes 51
32227760-29903860-75177444 10797-10799 29903860 denotes 52
32227760-29288933-75177445 10800-10802 29288933 denotes 53
32227760-32211816-75177446 10911-10915 32211816 denotes 1954
32227760-32171076-75177447 10988-10990 32171076 denotes 14
32227760-19808375-75177448 11360-11362 19808375 denotes 55
32227760-19453650-75177449 11529-11531 19453650 denotes 56
32227760-28209222-75177450 11654-11656 28209222 denotes 57
32227760-32171076-75177451 12603-12605 32171076 denotes 14
32227760-32211816-75177452 12606-12608 32211816 denotes 54
32227760-32125452-75177453 12612-12614 32125452 denotes 60
32227760-32191259-75177454 12633-12635 32191259 denotes 59
32227760-32191259-75177455 12654-12656 32191259 denotes 59
32227760-32191259-75177456 13080-13082 32191259 denotes 59
32227760-8227822-75177457 13253-13255 8227822 denotes 61
32227760-30429050-75177458 13497-13499 30429050 denotes 62
32227760-9631869-75177459 13694-13696 9631869 denotes 63
32227760-15207952-75177460 14599-14601 15207952 denotes 66
32227760-32048163-75177461 14733-14735 32048163 denotes 44
32227760-29449338-75177462 14852-14854 29449338 denotes 11
32227760-29102084-75177463 14855-14857 29102084 denotes 12
32227760-32191259-75177464 15234-15236 32191259 denotes 59
32227760-32171076-75177465 15310-15312 32171076 denotes 14
32227760-32007143-75177466 15313-15315 32007143 denotes 67
32227760-32167524-75177467 15316-15318 32167524 denotes 68
32227760-26643266-75177468 16287-16289 26643266 denotes 69